NCT04317781 2024-07-31Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 8 charts
NCT02420873 2018-08-28An Open-label Phase II Study of Lorvotuzumab MertansineM.D. Anderson Cancer CenterPhase 2 Completed9 enrolled 7 charts